Krystal Biotech Inc (KRYS)
$332.29 +2.38% Close Oct 30, 2026 Live
Krystal Biotech stock today
Krystal Biotech closed at $332.29 on October 30, 2026, up 2.38% on the day. Over the past year it returned +75.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $9.80 billion.
$200.00$300.00
NovJan 2026MarMayJulSep
| Period | KRYS | S&P 500 (SPY) |
|---|---|---|
| 1 month | -0.1% | -0.9% |
| 3 months | -9.4% | +2.1% |
| Year to date | +34.8% | +11.7% |
| 1 year | +75.7% | +12.4% |
| 3 years | +185.5% | +88.5% |
| 5 years | +563.4% | +76.0% |
Key statistics
- Market value
- $9.80B
- P/E (trailing)
- 41.7
- Forward P/E
- 40.2
- Price / sales
- 22.2
- 52-week range
- $189.08 to $378.15
- Next report
- Nov 2, 2026
About Krystal Biotech
Develops gene therapies and biologics for rare genetic skin disorders and blistering diseases.
Sector: Health Care
More on Krystal Biotech
- Financials: revenue, earnings and segmentsRevenue +34% in the year to Dec 2025
- Valuation: P/E history and peersP/E 41.7, median 52.2 at its last 3 year ends
- Returns: what $1,000 became$1,000 five years ago is $6,634 today
No forecast, no recommendation. This page describes Krystal Biotech Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.